Aclarion Authorized To Repurchase Up To $2.5 Mln Of Shares
(RTTNews) - Aclarion, Inc.(ACON), a healthcare technology company, said on Wednesday that its board has authorized a share repurchase program of up to $2.5 million of shares. The company plans to execute the share repurchase drive over the next 12 months.
Brent Ness, CEO of Aclarion, said: "We believe our shares represent a compelling value at current levels, and we view this program as a flexible and opportunistic tool to enhance shareholder value while continuing to invest in the clinical adoption and expansion of Nociscan."
Aclarion intends to fund this repurchase program using existing cash and cash equivalents.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.